FDA finally speeds up approval for ovarian cancer
Post# of 72440
"However, clinical trials for approval of ovarian cancer drugs seem to be moving fast. There is definitely a greater sense of urgency for treating ovarian cancer these days from pharmaceutical companies. Another study from Allied Market Research unveils that the ovarian cancer drug market would garner $111.9 billion by 2020 , confirming that research in this area is big business."
http://www.europeanpharmaceuticalreview.com/3...cer-drugs/